Alaunos Therapeutics Inc (TCRT)
1.30
-0.06
(-4.41%)
USD |
NASDAQ |
May 03, 16:00
1.31
+0.01
(+0.77%)
Pre-Market: 20:00
Alaunos Therapeutics Profit Margin (Quarterly): -784.3K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -784.3K% |
September 30, 2023 | |
June 30, 2023 | -219.3K% |
March 31, 2023 | |
December 31, 2022 | -83.26K% |
September 30, 2022 | -304.1% |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | -5.71K% |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | -10.97K% |
December 31, 2017 | -831.1% |
Date | Value |
---|---|
September 30, 2017 | -794.8% |
June 30, 2017 | -805.4% |
March 31, 2017 | -969.8% |
December 31, 2016 | -702.8% |
September 30, 2016 | -679.2% |
June 30, 2016 | -7.73K% |
March 31, 2016 | -610.4% |
December 31, 2015 | -493.8% |
September 30, 2015 | -972.2% |
June 30, 2015 | -5.22K% |
March 31, 2015 | -28.76K% |
December 31, 2014 | -3.06K% |
September 30, 2014 | -962.6% |
June 30, 2014 | -2.79K% |
March 31, 2014 | -4.86K% |
December 31, 2013 | -4.45K% |
September 30, 2013 | -8.36K% |
June 30, 2013 | -9.35K% |
March 31, 2013 | -6.40K% |
December 31, 2012 | -15.11K% |
September 30, 2012 | -8.91K% |
June 30, 2012 | -11.81K% |
March 31, 2012 | -12.24K% |
December 31, 2011 | -6.62K% |
September 30, 2011 | -401.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-784.3K%
Minimum
Dec 2023
-304.1%
Maximum
Sep 2022
-218.6K%
Average
-83.26K%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -159.8% |
Return on Assets | -103.8% |
Return on Invested Capital | -127.6% |
Operating Margin (Quarterly) | -336.0K% |
Return on Net Operating Assets | -484.0% |